Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-08-09

Clinical Trial Update: Analysis of the Impact of HCV Treatment by Last Generation Direct Antiviral Agents (DAA) on Antiviral Immunity and HIV DNA Reservoir in Coinfected HIV-HCV Patients [NA]

View source ↗

Summary

This clinical trial update analyzes how last-generation hepatitis C direct-acting antivirals influence antiviral immunity and the HIV DNA reservoir in patients …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Direct-acting antiviral agents (DAA) for Hepatitis C

Snippet

Sponsor: Assistance Publique Hopitaux De Marseille | Conditions: HIV Associated HCV | NA | Status: UNKNOWN